Polyrizon Ltd. funding
Polyrizon Ltd., a biotechnology company based in Raanana, Israel, filed a Form D with the SEC on September 10, 2026 and reported $4M raised. It filed 2 new offerings in this period, totaling $7.5M.
Amount raised$4M
Offering size$4M
Filed with the SECSeptember 10, 2026
First saleSeptember 3, 2026
IndustryBiotechnology
SecuritiesOptions or warrants, Security to be acquired on exercise
LocationRaanana, Israel
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Sep 10
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| September 10, 2026 | $4M | $4M | Options or warrants, Security to be acquired on exercise |
| April 23, 2026 | $3.5M | $3.5M | Options or warrants, Security to be acquired on exercise |
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology